Halozyme Therapeutics shares owned by Hudson Bay Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hudson Bay Capital Management
from 13F filings
Historical chart of Hudson Bay Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Hudson Bay Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $8.4M | 125k | 67.30 |
| 2025-09-30 | $244k | 3.3k | 73.34 |
| 2025-06-30 | $871k | 17k | 52.02 |
| 2020-03-31 | $2.4M | 135k | 17.99 |
| 2019-12-31 | $3.3M | 185k | 17.73 |
| 2019-09-30 | $2.7M | 175k | 15.51 |
| 2019-06-30 | $3.0M | 175k | 17.18 |
| 2019-03-31 | $2.3M | 145k | 16.10 |
| 2018-12-31 | $2.1M | 145k | 14.63 |
More positions owned by Hudson Bay Capital Management
View all positions for Hudson Bay Capital Management